With IPS HEART's stem cell therapy that replaces lost/damaged muscle, we start to actually cure the underlying disease itself vs. taking drugs daily that merely just treat the symptoms. IPS HEART is focused on the world's largest disease to fatal rare diseases which currently have no approved therapies for actual disease modification. IPS HEART is delivering a new class of cellular medicines with a transformative impact that can create new heart muscle and new skeletal muscle.
We are committed to transforming the lives of patients suffering devastating disease. From heart attack/heart failure to Duchenne Muscular Dystrophy, we tackle the most challenging conditions head vs. current therapeutics that can only provide symptomatic relief or at best slow the rate of decline in these devastating diseases.
We believe transformative care that will extend life as well as taking DMD patients out of their wheel chairs should be the goal, not just myopically restoring a missing gene that cannot create new muscle. Similarly for heart attack patients, we believe generating new heart muscle that repairs the #1 source of morbidity worldwide should be the goal.
We are advancing a pipeline of two single-course stem cell therapeutics intended to safely and durably create new heart muscle and new skeletal muscle in cardiac & DMD patients.
Our proprietary platform uses recently discovered induced pluripotent stem cells (iPSCs) which can create an unlimited number of new cells to repair irreversibly damaged muscle/tissue.